Groupe Bruxls Lm ADR (OP:GBLBY)
Price and Volume
Detailed Quote| Volume | 1,217 |
| Open | 9.296 |
| Bid (Size) | N/A (0) |
| Ask (Size) | N/A (0) |
| Prev. Close | 9.296 |
| Today's Range | 9.460 - 9.460 |
| 52wk Range | 7.380 - 44.51 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Performance
52-Week Range
78.7% below 52-week high
9.460
7.3852W Low
44.5152W High
1 Week
8.911W Low
9.351W High
Groupe Bruxls Lm ADR (GBLBY) traded between $7.38 and $44.51 over the past 52 weeks and last traded at $9.46, 78.7% below its 52-week high. Over the past week it ranged between $8.91 and $9.35.
Past 12 Months
1W
+$0.36
1M
+$2.08
3M
+$0.62
6M
-$0.56
YTD
+$0.71
1Y
+$0.54
GBLBY was +6.1% over the past year, -5.6% over six months, +8.1% year to date, +3.9% in the last week.
12 Months vs Market
GBLBY
+6.1%
DIA
+8.3%
SPY
+8.5%
QQQ
+5.3%
IWM
+11.8%
Over the past 12 months GBLBY returned +6.1% versus DIA (Dow) +8.3%, SPY (S&P 500) +8.5%, QQQ (Nasdaq 100) +5.3% and IWM (Russell 2000) +11.8%.
Volume & Liquidity
1.13× 3-mo avg
Today 1,217
3-mo avg 1.1K
1W
1.5K
1M
913.0
3M
1.1K
6M
1.2K
YTD
1.6K
1Y
1.5K
GBLBY most recently traded 1,217 shares against a 3-month average daily volume of 1.1K.
Frequently Asked Questions
Is Groupe Bruxls Lm ADR publicly traded?
Yes, Groupe Bruxls Lm ADR is publicly traded.
What exchange does Groupe Bruxls Lm ADR trade on?
Groupe Bruxls Lm ADR trades on the OTC Traded
What is the ticker symbol for Groupe Bruxls Lm ADR?
The ticker symbol for Groupe Bruxls Lm ADR is GBLBY on the OTC Traded
What is the current price of Groupe Bruxls Lm ADR?
The current price of Groupe Bruxls Lm ADR is 9.460
When was Groupe Bruxls Lm ADR last traded?
The last trade of Groupe Bruxls Lm ADR was at 11/06/26 10:55 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
